Find clinical trials for Moderna. Search for Moderna clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 454
Active & ResponsiveNew
Systems Biological Analysis of Immune Responses to RSV Vaccine
for
Respiratory Syncytial Virus (RSV)
Location: Decatur GA
Sponsor: Emory University
Sex: All
Age: 60+
Code: NCT07185399
Recruiting
Active & ResponsiveNew
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
for
SARS-CoV-2
Location: Atlanta GA, Decatur GA, Baton Rouge LA, Gulfport MS,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT06585241
Recruiting
Active & ResponsiveNew
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
for
COVID-19
Location: Atlanta GA, Baton Rouge LA, New Orleans LA, Gulfport MS,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT07089706
Recruiting
Active & ResponsiveNew
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Nashville TN
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT07116616
Phase1, Phase2, Recruiting
Active & Responsive
The Impact of COVID-19 on Maternal and Neonatal Outcomes
for
COVID-19, Pregnancy; Infection
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: Female
Age: 14 - 55
Code: NCT05197621
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.
for
COVID-19, Long Haul
Location: Bethesda MD
Sponsor: Well- Konnect Healthcare Services and Research Firm
Sex: All
Age: 18 - 65
Code: NCT06441955
Recruiting
Active & Responsive
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
for
Propionic Acidemia
Location: Los Angeles CA, Ann Arbor MI, New York NY, Durham NC,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05130437
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
for
SARS-CoV-2
Location: Bessemer AL, Montebello CA, Doral FL, Jacksonville FL,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0 - 5
Code: NCT05436834
Phase3, Recruiting
Active & Responsive
A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors
for
Advanced Solid Tumors
Location: Grand Rapids MI, San Antonio TX, West Valley City UT
Sponsor: ModernaTX, Inc.
Sex: All
Age: 18+
Code: NCT06880549
Phase1, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.